BONUCCELLI, UBALDO
 Distribuzione geografica
Continente #
NA - Nord America 31.400
EU - Europa 12.160
AS - Asia 7.509
SA - Sud America 650
AF - Africa 469
OC - Oceania 67
Continente sconosciuto - Info sul continente non disponibili 12
Totale 52.267
Nazione #
US - Stati Uniti d'America 30.639
IT - Italia 4.703
CN - Cina 3.069
SG - Singapore 2.168
SE - Svezia 1.925
BG - Bulgaria 1.193
DE - Germania 1.078
HK - Hong Kong 849
CA - Canada 745
GB - Regno Unito 606
TR - Turchia 588
BR - Brasile 582
RU - Federazione Russa 569
UA - Ucraina 547
VN - Vietnam 484
FI - Finlandia 474
AT - Austria 312
CH - Svizzera 233
CI - Costa d'Avorio 202
FR - Francia 167
IN - India 149
NG - Nigeria 139
SN - Senegal 73
BE - Belgio 69
NL - Olanda 66
PL - Polonia 51
AU - Australia 50
KR - Corea 29
CZ - Repubblica Ceca 28
IE - Irlanda 19
AR - Argentina 18
TW - Taiwan 18
NZ - Nuova Zelanda 17
ES - Italia 16
IL - Israele 16
LT - Lituania 16
GR - Grecia 15
JP - Giappone 14
PE - Perù 13
ZA - Sudafrica 13
BD - Bangladesh 12
IR - Iran 12
MA - Marocco 12
RO - Romania 12
ID - Indonesia 11
IQ - Iraq 11
CO - Colombia 10
EG - Egitto 10
EU - Europa 10
BJ - Benin 9
HU - Ungheria 9
MX - Messico 9
PK - Pakistan 9
UZ - Uzbekistan 9
VE - Venezuela 9
DK - Danimarca 8
EC - Ecuador 8
AM - Armenia 6
HR - Croazia 6
PT - Portogallo 6
EE - Estonia 5
AZ - Azerbaigian 4
BN - Brunei Darussalam 4
CL - Cile 4
DZ - Algeria 4
LV - Lettonia 4
BA - Bosnia-Erzegovina 3
GE - Georgia 3
JM - Giamaica 3
JO - Giordania 3
KG - Kirghizistan 3
LK - Sri Lanka 3
MD - Moldavia 3
ME - Montenegro 3
MY - Malesia 3
NO - Norvegia 3
NP - Nepal 3
OM - Oman 3
PH - Filippine 3
PY - Paraguay 3
SA - Arabia Saudita 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
KE - Kenya 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LU - Lussemburgo 2
PS - Palestinian Territory 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
A1 - Anonimo 1
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
CU - Cuba 1
DO - Repubblica Dominicana 1
Totale 52.253
Città #
Woodbridge 4.155
Fairfield 3.473
Ashburn 3.011
Ann Arbor 2.740
Houston 2.580
Chandler 2.014
Seattle 1.459
Serra 1.287
Santa Clara 1.239
Cambridge 1.225
Sofia 1.190
Wilmington 1.177
Singapore 1.033
Milan 977
Shanghai 888
Hong Kong 827
Jacksonville 779
Beijing 728
New York 720
Ottawa 690
Princeton 526
Boardman 510
Lawrence 462
Medford 437
Izmir 370
Nanjing 355
Des Moines 313
Vienna 281
Dearborn 242
Florence 219
Bern 213
Abidjan 202
Istanbul 199
Dong Ket 192
Pisa 173
Frankfurt am Main 169
Nanchang 158
San Diego 150
Jüchen 145
Redwood City 140
Lagos 139
Lancaster 128
Rome 111
Kunming 101
London 98
Bremen 90
Norwalk 83
Shenyang 77
Ogden 74
Dakar 73
Boulder 63
Pune 63
Hebei 62
Los Angeles 62
Brussels 60
Changsha 57
Guangzhou 52
Tianjin 47
Düsseldorf 44
Jiaxing 44
Council Bluffs 43
Hefei 42
Lucca 42
Fuzhou 40
Washington 36
Warsaw 33
Nuremberg 32
São Paulo 32
Belo Horizonte 29
Dallas 28
Hangzhou 28
Quanzhou 28
Helsinki 26
Auburn Hills 25
Cascina 24
Phoenix 24
Livorno 22
Nürnberg 22
Verona 22
Vicopisano 22
Jinan 20
Orange 20
Trieste 20
Chicago 19
Munich 19
Chengdu 18
Detroit 18
Rio de Janeiro 18
Toronto 18
Kent 17
Torino 17
Falls Church 14
Massa 14
Melbourne 14
Radomsko 14
Auckland 13
Changchun 13
Portsmouth 13
Shenzhen 13
Wuhan 13
Totale 40.101
Nome #
Il fenomeno dell'abitudine del riflesso trigemino-faciale: confronto tra malattia di Parkinson e atrofia multisistemica. 443
Actigraphic sleep detection: an artificial intelligence approach 321
Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study 258
Thyroid hormone levels in the cerebrospinal fluid correlate with disease severity in euthyroid patients with Alzheimer's disease 233
Clinical Correlates of Cerebral Amyloid Deposition in Parkinson's Disease Dementia: Evidence from a PET Study 217
Vascular Factors and Mitochondrial Dysfunction: a Central Role in the Pathogenesis of Alzheimer's Disease. 211
α-Synuclein Aggregates with β-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy Subjects 205
Novel MTCYB mutation in a young patient with recurrent stroke-like episodes and status epilepticus. 199
Occurrence of seizures and EEG interictal epileptiform discharges in AD patients and their correlation with clinical features: a cross-sectional study 199
Endothelium and oxidative stress: The Pandora's Box of cerebral (and non-only) small vessel disease? 197
Descrizione di un caso di Neuromiotonia associata a tetania normocalcemica 196
Vascular Function Is Improved After an Environmental Enrichment Program: The Train the Brain-Mind the Vessel Study 192
Myopathic involvement and mitochondrial pathology in Kennedy disease and in other motor neuron diseases 185
Epilepsy occurrence in patients with Alzheimer's disease: clinical experience in a tertiary dementia center 185
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease 178
α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity 177
A case of pelvic floor myoclonic jerk syndrome. 176
α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise 171
Oxidative stress in cerebral small vessel disease dizziness patients, basally and after polyphenol compound supplementation 171
Cyclic alternating pattern and interictal epileptiform discharges during morning sleep after sleep deprivation in temporal lobe epilepsy 168
Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI/MRS study 166
Prevalence of Parkinson's disease and other types of parkinsonism in the Aeolian Archipelago, Sicily 166
Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment. 166
Sleep Disorders in an elderly population and their relationship with cognitive symptoms: an epidemiological survey 166
Intra-arterial tissue plasminogen activator and abciximab in patients with acute basilar artery occlusion 165
The Neuroanatomy of the Reticular Nucleus Locus Coeruleus in Alzheimer's Disease. 165
Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction 164
Mitochondrial DNA haplogroups may influence Fabry disease phenotype 164
Cytogenetic alterations in lymphocytes of Alzheimer's disease and Parkinson's disease patients 164
Acute and chronic effects of clozapine in essential tremor 163
Mapping Cortical Degeneration in ALS with Magnetization Transfer Ratio and Voxel-Based Morphometry 163
Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease 163
Chronic Migraine with Medication Overuse and OnabotulinumtoxinA: Two Positive Case Reports of a Modified Injection Protocol 163
Hereditary spastic paraparesis in adults. A clinical and genetic perspective from Tuscany 162
Activity-based diary for Parkinson's disease, 159
Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study 159
A clinical and laboratory study evaluating the profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis 159
Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study. 159
A whole-brain analysis in de novo Parkinson disease 158
Cerebellar ataxia with complete clinical recovery and resolution of MRI lesions related to central pontine myelinolysis: case report and literature review 158
The precuneus-a witness for excessive aβ gathering in alzheimer's disease pathology 158
A pilot psychometric study of aberrant salience state in patients with Parkinson's disease and its association with dopamine replacement therapy. 157
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 157
DISRUPTION OF SLEEP-WAKE CONTINUUM IN MYOTONIC DYSTROPHY TYPE I: SLEEP MACROSTRUCTURAL AND MICROSTRUCTURAL FINDINGS 157
Mesolimbic dopaminergic dysfunction in Parkinson's disease depression: evidence from a 123I-FP-CIT SPECT investigation. 156
Relation between plasmatic and cerebrospinal fluid oxidative stress biomarkers and intrathecal ig synthesis in multiple sclerosis patients 155
Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia 153
Perioperative atrial fibrillation and the long-term risk of ischemic stroke 153
Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients 153
Caudate dopaminergic denervation and visual hallucinations: Evidence from a 123I-FP-CIT SPECT study 152
Effect of metadoxine on striatal dopamine levels in C57 black mice 151
Cerebral sinus venous thrombosis: Clinical and pathogenetic perspectives from Tuscany 151
Thyroid function and oral TRH in amyotrophic lateral sclerosis 150
Reduced luteinizing hormone secretion in women with Parkinson's disease 150
A case of sarcoidosis presenting as a non-specific intramedullary lesion 150
Identification and determination of 3,4-dihydroxyphenylacetaldehyde, the dopamine metabolite in in vivo dialysate from rat striatum. 150
A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting 150
Role of dopamine agonists in Parkinson's disease: an update 149
Spectrum of addictions in Parkinson's disease: from dopamine dysregulation syndrome to impulse control disorders 149
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial 149
Brain-Derived Neurotrophic Factor (BDNF) and Serotonin Transporter (SERT) in Platelets of Patients with Mild Huntington’s Disease: Relationships with Social Cognition Symptoms 148
Association Between CSF Beta-Amyloid and Apathy in Early-Stage Alzheimer Disease 148
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients 147
Prefrontal cortex, dopamine, and jealousy endophenotype. 147
SUNA syndrome with seasonal pattern 147
Postpartum headache due to spontaneous cervical artery dissection 147
Aerobic rehabilitation program for improving muscle function in Parkinson's disease 147
IV amantadine improves chorea in Huntington's disease: an acute randomized, controlled study 146
Dopamine agonists in the treatment of Parkinson's disease 146
SSRIs do not worsen Parkinson's disease: Evidence from an open-label, prospective study 146
Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes 146
Epidemiology and cerebrovascular events related to cervical and intracranial arteries dissection: the experience of the city of Pisa 144
Iowa gambling task in Parkinson's disease 143
Diabetes is associated with postural and cognitive domains in Parkinson's disease. Results from a single-center study. 143
Acute encephalopathy of the temporal lobes leading to m.3243A>G. When MELAS is not always MELAS 143
Efficacy of a combined therapeutic approach in the management of Pisa Syndrome 143
Clinical pharmacokinetics of cabergoline 142
Evidences of Reduced Antioxidant Activity in Patients with Chronic Migraine and Medication-Overuse Headache 142
Nummular headache dramatically responsive to indomethacin 141
Antipsychotic drugs in Huntington's disease 141
A pilot trial of deferiprone for neurodegeneration with brain iron accumulation 140
Multiple system atrophy is distinguished from idiopathic Parkinson's disease by the arginine growth hormone stimulation test 140
Localized calcific hematoma of the scalp presenting as a nummular-like headache: a case report. 139
The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-na?ve patients with Parkinson's disease. 139
Preferential occurrence of attacks during night sleep and/or upon awakening negatively affects migraine clinical presentation 139
Imaging in Glucocerebrosidase-Associated Parkinsonism: Current Status and Implications for Pathophysiology. 139
Cerebral microbleeds in patients with mild cognitive impairment and small vessel disease: The Vascular Mild Cognitive Impairment (VMCI)-Tuscany study 139
Effects of peripheral and central catechol-O-methyltransferase inhibition on striatal extracellular levels of dopamine: a microdialysis study in freely moving rats 138
Event-based prospective memory in newly diagnosed, drug-naive Parkinson's disease patients 138
Relationship between neuropsychological impairment and grey and white matter changes in adult-onset myotonic dystrophy type 1 138
Levodopa in the treatment of Parkinson's disease: current controversies 137
NREM sleep transient events in fronto-temporal dementia: beyond sleep stage architecture 137
Bedtime cabergoline in Parkinson's disease patients with excessive daytime sleepiness induced by dopamine agonists 136
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease 136
Decision making in de novo Parkinson's disease 136
Iowa Gambling Task in de novo Parkinson's disease: a comparison between good and poor performers 136
Gait dynamics in Pisa syndrome and Camptocormia: the role of stride length and hip kinematics 136
Seven tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder 136
Clinical and pharmacokinetic evaluation of L-dopa and cabergoline cotreatment in Parkinson's disease, 135
Depressive symptoms in Parkinson's disease 135
Totale 16.230
Categoria #
all - tutte 139.511
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.511


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.374 0 0 0 0 0 0 0 0 0 539 650 185
2020/20214.108 363 266 273 195 528 249 301 364 372 348 244 605
2021/20224.925 85 206 101 328 992 673 97 273 338 142 262 1.428
2022/20236.192 756 746 418 522 822 832 56 465 1.012 35 438 90
2023/20244.627 637 501 562 277 621 884 182 185 80 82 197 419
2024/20258.593 56 531 145 717 957 1.140 1.017 724 1.404 1.902 0 0
Totale 53.032